• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用基因定义的肿瘤类器官建立体内转移模型。

An In Vivo Metastasis Model Using Genotype-Defined Tumor Organoids.

机构信息

Division of Genetics, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.

Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kanazawa, Japan.

出版信息

Methods Mol Biol. 2024;2828:57-68. doi: 10.1007/978-1-0716-4023-4_6.

DOI:10.1007/978-1-0716-4023-4_6
PMID:39147970
Abstract

Recent cancer genome analyses have identified frequently mutated genes that are responsible for the development and malignant progression of cancers, including colorectal cancer (CRC). We previously constructed mouse models that carried major driver mutations of CRC, namely Apc, Kras, Tgfbr2, Trp53, and Fbxw7, in combinations. Comprehensive histological analyses of the models showed a link between mutation combinations and malignant phenotypes, such as invasion, epithelial-mesenchymal transition (EMT), and metastasis. The major cause of cancer-related death is metastasis, making it important to understand the mechanism underlying metastasis in order to develop novel therapeutic strategies. To this end, we have established intestinal tumor-derived organoids from different genotyped mice and generated liver metastasis models via transplantation of the organoids into the spleen. Through histological and imaging analyses of the transplantation models, we have determined that the combination of Apc, Kras, Tgfbr2, and Trp53 mutations promotes liver metastasis at a high incidence. We also demonstrated polyclonal metastasis of tumor cell clusters consisting of genetically and phenotypically distinct cells through our model analysis. These organoid transplantation models recapitulate human CRC metastasis, constituting a useful tool for basic and clinical cancer research as a preclinical model. We herein report the experimental protocols of the organoid culture and generation of metastasis models.

摘要

最近的癌症基因组分析已经确定了经常发生突变的基因,这些基因是癌症(包括结直肠癌)发生和恶性进展的原因。我们之前构建了携带结直肠癌主要驱动突变的小鼠模型,即 Apc、Kras、Tgfbr2、Trp53 和 Fbxw7 的组合。这些模型的全面组织学分析表明,突变组合与侵袭、上皮-间充质转化(EMT)和转移等恶性表型之间存在关联。癌症相关死亡的主要原因是转移,因此了解转移的机制对于开发新的治疗策略非常重要。为此,我们已经从不同基因型的小鼠中建立了肠道肿瘤衍生的类器官,并通过将类器官移植到脾脏中来生成肝转移模型。通过对移植模型的组织学和成像分析,我们确定 Apc、Kras、Tgfbr2 和 Trp53 突变的组合以高发生率促进肝转移。我们还通过我们的模型分析证明了由遗传和表型不同的细胞组成的肿瘤细胞簇的多克隆转移。这些类器官移植模型再现了人类结直肠癌的转移,构成了一种用于基础和临床癌症研究的有用工具,作为临床前模型。我们在此报告类器官培养和转移模型生成的实验方案。

相似文献

1
An In Vivo Metastasis Model Using Genotype-Defined Tumor Organoids.利用基因定义的肿瘤类器官建立体内转移模型。
Methods Mol Biol. 2024;2828:57-68. doi: 10.1007/978-1-0716-4023-4_6.
2
Combined Mutation of , and Effectively Drives Metastasis of Intestinal Cancer.同时突变 和 可有效驱动肠癌转移。
Cancer Res. 2018 Mar 1;78(5):1334-1346. doi: 10.1158/0008-5472.CAN-17-3303. Epub 2017 Dec 27.
3
Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation.突变型p53通过获得与复杂腺管形成相关的侵袭性促进肠道癌进展。
Oncogene. 2017 Oct 19;36(42):5885-5896. doi: 10.1038/onc.2017.194. Epub 2017 Jun 19.
4
In Vitro and In Vivo Models for Metastatic Intestinal Tumors Using Genotype-Defined Organoids.利用基因型定义的类器官建立转移性肠道肿瘤的体外和体内模型。
Methods Mol Biol. 2023;2691:19-30. doi: 10.1007/978-1-0716-3331-1_2.
5
Development and Characterization of a Genetic Mouse Model of KRAS Mutated Colorectal Cancer.KRAS 突变型结直肠癌的遗传小鼠模型的建立与鉴定。
Int J Mol Sci. 2019 Nov 13;20(22):5677. doi: 10.3390/ijms20225677.
6
MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer.MEK 抑制可抑制 KRAS 突变型胃癌的转移进展。
Cancer Sci. 2022 Mar;113(3):916-925. doi: 10.1111/cas.15244. Epub 2022 Jan 7.
7
Trp53 null and R270H mutant alleles have comparable effects in regulating invasion, metastasis, and gene expression in mouse colon tumorigenesis.Trp53 缺失和 R270H 突变等位基因在调控小鼠结肠癌发生中的侵袭、转移和基因表达方面具有相当的作用。
Lab Invest. 2019 Oct;99(10):1454-1469. doi: 10.1038/s41374-019-0269-y. Epub 2019 May 31.
8
CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.CRISPR-Cas9 介导的肠道肿瘤类器官基因敲除为结直肠癌驱动基因提供功能验证。
Proc Natl Acad Sci U S A. 2019 Jul 30;116(31):15635-15644. doi: 10.1073/pnas.1904714116. Epub 2019 Jul 12.
9
Gain-of-Function p53 Mutation Acts as a Genetic Switch for TGFβ Signaling-Induced Epithelial-to-Mesenchymal Transition in Intestinal Tumors.功能获得性 p53 突变作为 TGFβ 信号诱导肠道肿瘤上皮间质转化的遗传开关。
Cancer Res. 2024 Jan 2;84(1):56-68. doi: 10.1158/0008-5472.CAN-23-1490.
10
KRAS Mutation-Responsive miR-139-5p inhibits Colorectal Cancer Progression and is repressed by Wnt Signaling.KRAS 突变响应的 miR-139-5p 抑制结直肠癌细胞进展,受 Wnt 信号抑制。
Theranostics. 2020 Jun 5;10(16):7335-7350. doi: 10.7150/thno.45971. eCollection 2020.

本文引用的文献

1
Frequent loss of metastatic ability in subclones of Apc, Kras, Tgfbr2, and Trp53 mutant intestinal tumor organoids.Apc、Kras、Tgfbr2 和 Trp53 突变肠肿瘤类器官亚克隆中频繁丧失转移能力。
Cancer Sci. 2023 Apr;114(4):1437-1450. doi: 10.1111/cas.15709. Epub 2023 Jan 6.
2
Nano-scale physical properties characteristic to metastatic intestinal cancer cells identified by high-speed scanning ion conductance microscope.高速扫描离子电导显微镜鉴定转移性肠道癌细胞的纳米级物理特性。
Biomaterials. 2022 Jan;280:121256. doi: 10.1016/j.biomaterials.2021.121256. Epub 2021 Nov 13.
3
Malignant subclone drives metastasis of genetically and phenotypically heterogenous cell clusters through fibrotic niche generation.
恶性亚克隆通过生成纤维性生态位驱动遗传和表型异质性细胞簇的转移。
Nat Commun. 2021 Feb 8;12(1):863. doi: 10.1038/s41467-021-21160-0.
4
Loss of wild-type p53 promotes mutant p53-driven metastasis through acquisition of survival and tumor-initiating properties.野生型 p53 的缺失会通过获得生存和肿瘤起始特性促进突变型 p53 驱动的转移。
Nat Commun. 2020 May 11;11(1):2333. doi: 10.1038/s41467-020-16245-1.
5
Combined Mutation of , and Effectively Drives Metastasis of Intestinal Cancer.同时突变 和 可有效驱动肠癌转移。
Cancer Res. 2018 Mar 1;78(5):1334-1346. doi: 10.1158/0008-5472.CAN-17-3303. Epub 2017 Dec 27.
6
Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation.突变型p53通过获得与复杂腺管形成相关的侵袭性促进肠道癌进展。
Oncogene. 2017 Oct 19;36(42):5885-5896. doi: 10.1038/onc.2017.194. Epub 2017 Jun 19.
7
A collective route to metastasis: Seeding by tumor cell clusters.转移的集体途径:肿瘤细胞簇的播种。
Science. 2016 Apr 8;352(6282):167-9. doi: 10.1126/science.aaf6546.
8
Suppressing TGFβ signaling in regenerating epithelia in an inflammatory microenvironment is sufficient to cause invasive intestinal cancer.在炎症微环境中抑制再生上皮中的 TGFβ 信号足以导致侵袭性肠道癌。
Cancer Res. 2015 Feb 15;75(4):766-76. doi: 10.1158/0008-5472.CAN-14-2036.
9
Molecular origins of cancer: Molecular basis of colorectal cancer.癌症的分子起源:结直肠癌的分子基础
N Engl J Med. 2009 Dec 17;361(25):2449-60. doi: 10.1056/NEJMra0804588.
10
Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene.携带截短型Apc基因的小鼠新生肠息肉中Apc杂合性缺失及异常组织构建。
Proc Natl Acad Sci U S A. 1995 May 9;92(10):4482-6. doi: 10.1073/pnas.92.10.4482.